Dendreon's Infectious Influence on Biotechs
10 of This Week's Biggest Losers
Inside Wall Street: This Tiny Stem Cell Biotech Has the Vatican's Backing
Daily Blogwatch: Choosing Between Your BlackBerry and Your Wife
Inside Wall Street: Is ImmunoCellular Another Rising Star in Biotech?
Inside Wall Street: Is This Tiny Aussie Biotech the Next Dendreon?
Deutsche Bank Initiates Amgen with a Hold, Dendreon with a Buy
Dendreon Slides on Fear Medicare May Not Cover Prostate Cancer Drug Provenge
Prostate Cancer Patients Face Shortage of Dendreon's Provenge Vaccine
Inside Wall Street: Why Hot Biotech Dendreon Could Get Even Hotter
Pharma's big movers: Amylin up on obesity drug, Hep C drug lifts Vertex
Dendreon shares soar as trading resumes
A closer look at Dendreon's new prostate cancer treatment
Not-as-bad economic data drives stocks higher
Bad economic news squashes stocks
Dendreon shares soar, as do prostate cancer patients' hopes